Table 1 The baseline characteristics of cancer patients before surgery
Variables | Non-PE group (N = 126) | PE group (N = 63) | P-value |
|---|---|---|---|
Age (y) | 63 (56–71) | 66 (56–71) | 0.756 |
Gender [No. (%)] | Â | Â | 0.837 |
 Female | 58 (46.03) | 30 (47.32) |  |
 Male | 68 (53.97) | 33 (52.38) |  |
BMI (kg/m2) |  |  | < 0.001 |
  < 22.03 | 51 (40.48) | 12 (19.05) |  |
 22.03–24.69 | 45 (35.71) | 18 (28.57) |  |
  ≥ 24.69 | 30 (23.81) | 33 (52.38) |  |
Tobacco abuse | 60 (47.62) | 27 (42.86) | 0.536 |
Alcohol abuse | 38 (30.16) | 16 (25.40) | 0.492 |
Hypertension | 27 (21.43) | 22 (34.92) | 0.046 |
Diabetes | 17 (13.49) | 4 (6.35) | 0.141 |
COPD | 32 (25.4) | 14 (22.22) | 0.632 |
Atrial fibrillation | 3 (2.38) | 2 (3.17) | 0.749 |
Hyperlipemia | 63 (50.0) | 25 (39.68) | 0.180 |
Coronary heart disease | 3 (2.4) | 1 (1.59) | 0.715 |
Cerebrovascular disease | 1 (0.84) | 1 (1.59) | 0.646 |
Central venous access | 42 (33.33) | 21 (33.33) | 1.000 |
Cancer-related characteristics [No. (%)] | |||
 Prior major surgery [No. (%)] | 0 (0.00) | 5 (7.94) | 0.001 |
  Tumor stage |  |  | 0.233 |
   Tis | 3 (2.38) | 0 (0.0) | 0.397 |
   I/mia | 32 (25.40) | 23 (36.51) |  |
   II | 37 (29.37) | 16 (25.40) |  |
   III | 37 (29.37) | 18 (28.57) |  |
   IV | 17 (13.49) | 6 (9.52) |  |
  Pathology |  |  | 0.882 |
   Adenocarcinoma | 70 (55.56) | 31 (49.21) |  |
   Squamous cell carcinoma | 39 (30.95) | 20 (31.75) |  |
   Neuroendocrine carcinoma | 7 (5.56) | 5 (7.94) |  |
   Sarcoma | 3 (2.38) | 2 (3.17) |  |
   Others | 7 (5.56) | 5 (7.94) |  |
  Cancer location |  |  | 0.137 |
   Thoracic cavity | 86 (68.3) | 43 (68.3) |  |
   Abdominopelvic cavity | 40 (31.7) | 20 (31.7) |  |
Neoadjuvant chemotherapy | 14 (11.11) | 7 (11.11) | 1.000 |
Neoadjuvant radiotherapy | 3 (2.38) | 1 (1.59) | 0.721 |
Preoperative anticoagulation | 11 (8.73) | 3 (4.76) | 0.326 |